Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2021-11-15 | 2023-04-06 | 149254 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2022-11-11 | 2023-03-30 | 174390 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Actual shortage | 2023-04-06 | 2025-01-07 | 188954 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2024-02-07 | 2024-05-24 | 218776 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-23 | 2017-12-18 | 13709 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-09-07 | 2018-03-20 | 21562 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-11 | 2018-06-07 | 10100 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-29 | 2019-09-12 | 79850 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2018-06-29 | 2018-09-19 | 53245 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-10 | 2023-08-11 | 198000 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-30 | 2025-03-17 | 211901 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-27 | 2025-03-17 | 214316 |
| PMS-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-24 | 2018-05-18 | 4219 |
| PMS-LACTULOSE SYR 667MG/ML | 667MG | SYRUP | Resolved | 2017-05-02 | 2017-05-18 | 8599 |
| PMS-LACTULOSE SYR 667MG/ML | 667MG | SOLUTION | Resolved | 2019-01-16 | 2019-07-31 | 72623 |
| PMS-LACTULOSE SYR 667MG/ML | 667MG | SOLUTION | Resolved | 2019-03-04 | 2019-06-11 | 77468 |
| PMS-LACTULOSE SYR 667MG/ML | 667MG | SYRUP | Resolved | 2017-05-25 | 2018-05-05 | 11301 |
| PMS-LACTULOSE SYR 667MG/ML | 667MG | SYRUP | Resolved | 2017-05-25 | 2017-06-16 | 11304 |
| PMS-LACTULOSE SYR 667MG/ML | 667MG | SYRUP | Resolved | 2017-05-25 | 2017-06-16 | 11315 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |